Skip to main content

Day: March 17, 2026

FBS Global Secures Exclusive Rights to Deploy Green and Intelligent Building Technologies Across International Markets

Strategic Agreement Expands Company’s Smart Infrastructure Capabilities and Positions FBS Global to Pursue Higher-Value Sustainable Building Opportunities Singapore, March 17, 2026 (GLOBE NEWSWIRE) — FBS Global Limited (Nasdaq: FBGL) (“FBS” or the “Company”), a green building contractor and interior fit-out specialist, today announced that it has secured exclusive commercialization rights across international markets for advanced green and intelligent building technologies, strengthening the Company’s capabilities in sustainable construction and next-generation building systems. The agreement grants FBS exclusive rights to deploy, promote, and commercialize innovative technologies designed to enhance digital building design, intelligent building systems and energy-efficient construction materials, supporting the Company’s strategy...

Continue reading

AI Editing Tools Are Fueling a New Era of Insurance Fraud, According to New Research from Verisk

One in three consumers would consider digitally altering an insurance claim image or document to strengthen their case – and that number rises to 55 percent of Generation Z. Three out of four insurers (76 percent) say manipulated media submissions have grown more sophisticated – even as confidence lags in detecting deepfakes at scale. New Verisk State of Insurance Fraud study points to a need for stronger collaboration, more connected systems and technology to help protect policyholders and preserve trust.JERSEY CITY, N.J., March 17, 2026 (GLOBE NEWSWIRE) — From adjusting the lighting in a photo to repairing a blurry image, AI‑powered image editing tools have become part of everyday life – and increasingly, part of the insurance claims process. New data from the Verisk State of Insurance Fraud study reveals that more than one...

Continue reading

21Shares AG (the “Issuer”): Publication of a Supplementary Prospectus

21Shares AG (the “Issuer”) LEI: 254900UWHMJRRODS3Z64 17 March 2026 Publication of Supplement to Base Prospectus of the Issuer A supplement dated 17 March 2026 to the Base Prospectus dated 8 January 2026 (the “Base Prospectus”) relating to the Exchange Traded Products Programme of the Issuer (the “Supplement”) has been approved by the Financial Conduct Authority (FCA) and is available for viewing. To view the Supplement in full, please click on the provided attachment or paste thefollowing URL into the address bar of your browser: https://www.21shares.com/en-uk/ir/prospectus. A copy of the Supplement will be submitted to the Financial Conduct Authority’s Electronic Submission Service and may shortly be viewed on the National Storage Mechanism at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Attention of Ms Eleni Katopodi,...

Continue reading

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

CERRITOS, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Liminatus today announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody designed to engage innate immune pathways and complement established immuno-oncology therapies. IBA101 is engineered to target the CD47 “don’t-eat-me” signal, a mechanism that enables tumor cells to evade innate immune surveillance. By enhancing macrophage-mediated tumor clearance and antigen presentation, IBA101 is designed to work alongside PD-1/PD-L1 checkpoint inhibitors, which remain the backbone of treatment across multiple solid tumor indications. The planned Phase 1 study is designed as a seamless clinical program, beginning with monotherapy dose escalation to evaluate safety, tolerability, and pharmacokinetics, followed by combination...

Continue reading

Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with aglatimagene besadenovec (aglatimagene or CAN-2409) surviving beyond 24 months, despite prior inadequate response to immune checkpoint inhibitors (ICI) and multiple adverse baseline prognostic factors. Among the patients surviving beyond 24 months and with PD-L1 status available, (17/20) 85% had baseline PD-L1 tumor proportion scores (TPS) below 50% (a population typically less responsive to ICI), supporting the potential of aglatimagene to upregulate PD-L1 in the tumor microenvironment and convert non-responders to ICI into responders. Median overall survival (mOS) was 25.4 months in the evaluable patients with inadequate response to ICI in...

Continue reading

Safe Pro Completes Latest U.S. Army Transforming in Contact 2.0 Exercise at Fort Hood, Texas

Army Rapid Fielding Exercise Validates the Capabilities of Safe Pro’s Artificial Intelligence Platform for Autonomous Battlefield Assessment and Planning AVENTURA, Fla., March 17, 2026 (GLOBE NEWSWIRE) — Safe Pro Group Inc. (Nasdaq: SPAI) (Safe Pro or the Company), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, today announced that it has completed its participation in the U.S. Army Transforming in Contact (TiC) 2.0 Autonomous Breach event where its patented AI tools were successfully utilized in real-world operational environments by soldiers and command personnel throughout the two week long operational exercise at Ft. Hood, TX. The U.S. Army’s wants to put $1 Billion dollars into Transforming in Contact (TiC) 2.0 to sponsor and fund the rapid equipping and testing of...

Continue reading

Academy Sports + Outdoors Reports Fourth Quarter and Fiscal 2025 Results

Fourth Quarter Sales Growth of 2.5%; Full Year Growth of 2.0% Fourth Quarter Comparable Sales Declined 1.6%; Full Year Declined 1.5% Fourth Quarter Diluted GAAP EPS of $1.98; up 4.8% Opened 24 new stores in 2025; Plans to Open an Additional 20 – 25 stores in 2026 Increased Quarterly Dividend by 15% Per Share; Fourth Year of Sequential Growth Releases 2026 Full Year Guidance; Expects Annual Sales Growth of 2% – 5% KATY, Texas, March 17, 2026 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its financial results for the fourth quarter and fiscal year ended January 31, 2026. “This past year marked an inflection point for Academy as we continued to gain market share and moved back to topline growth. During 2025, we put in place...

Continue reading

Lightbridge Receives Notice of Allowance on New Patent from the Canadian Intellectual Property Office

RESTON, Va., March 17, 2026 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, an advanced nuclear fuel technology company, today announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office (“CIPO”) for its nuclear fuel assembly design. Specifically, Canadian Patent Application No. 2,960,383, titled “Fuel Assembly,” covers 48 claims directed to fuel assemblies comprising helically twisted fuel elements arranged into a mixed grid pattern, as well as nuclear reactors incorporating such fuel assemblies. The allowed claims, stemming from an application originally filed in September 2015, describe fuel assemblies comprising a plurality of helically twisted fuel elements supported by a frame in a fuel rod bundle...

Continue reading

Youxin Technology Ltd Completes Strategic Asset Acquisition in Hainan Free Trade Port to Accelerate International Market Expansion

GUANGZHOU, CHINA, March 17, 2026 (GLOBE NEWSWIRE) — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced the completion of a strategic acquisition (the “Acquisition”) of a real estate asset with a market value of $5.52 million (RMB38.01 million) in the Hainan Free Trade Port (the “Hainan FTP”). The Acquisition represents an important step in the Company’s strategy to enhance its cross-border digital commerce capabilities and advance its expansion into international markets. The Hainan FTP has emerged as one of China’s most significant economic reform initiatives. Supported by preferential policies including zero tariffs, reduced tax rates,...

Continue reading

TON Strategy Company Sets Fourth Quarter and Full Year 2025 Conference Call for Tuesday, March 31, 2026 at 9:00 a.m. ET

LAS VEGAS, March 17, 2026 (GLOBE NEWSWIRE) — TON Strategy Company (Nasdaq: TONX), a digital asset treasury company dedicated to holding Toncoin ($TON), will hold a conference call on Tuesday, March 31, 2026 at 9:00 a.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2025. Financial results will be issued in a press release prior to the call. TON Strategy management will host the presentation. Date: Tuesday, March 31, 2026Time: 9:00 a.m. Eastern timeU.S. dial-in: 1-877-407-0789International dial-in: 1-201-689-8562Conference ID: 13759275 Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting to the conference call, please contact Gateway Group at 949-574-3860. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.